Dispersol Technologies

DisperSol Technologies provides consultancy solutions for formulation and processing technologies in drug manufacturing industries.

DisperSol Technologies was founded in 2007 and evolved from a research collaboration with the College of Pharmacy at The University of Texas at Austin. The focus of this collaboration was to adapt and apply a unique plastics processing technology to pharmaceutical manufacturing. KinetiSol emerged from this research as an innovative technology for the production of drug-polymer composite systems most notably for solubility/bioavailability enhancement of poorly water-soluble compounds. Since its inception, various applications for KinetiSol have been established in the field of drug delivery. DisperSol holds numerous patents related to the technology and the equipment as well as several pending patents. DisperSol Technologies provides expertise in formulation and processing technologies for solubility/bioavailability enhancement of poorly water-soluble drug molecules. DisperSol possesses a unique portfolio of technologies for the production of solubility enhanced systems that includes DisperSol’s proprietary KinetiSol technology. As a non-solvent, fusion-based process that minimizes thermal stress with highly efficient mixing, KinetiSol is uniquely positioned to generate amorphous solid dispersion systems with the most challenging APIs and with the broadest spectrum of pharmaceutical polymers. DisperSol has established a rapid KinetiSol feasibility program whereby the applicability of the process to any NCE can be determined rapidly and with relatively little API. Following a successful KinetiSol feasibility program, DisperSol is positioned to provide formulations development and manufacturing services to support pre-clinical and early-phase clinical studies. Toward the development of solubility enhanced formulations in general, DisperSol offers a variety of services including: formulation/process research and development for fusion and solvent-based processes, solid-state and chemical characterization, accelerated stability testing, in-vitro/in-vivo performance analysis, drug product manufacturing for pre-clinical and early-phase clinical studies, as well as formulation and process development consulting.